Lineage Cell Therapeutics
LCTX
#8801
Rank
NZ$0.19 B
Marketcap
$0.89
Share price
0.93%
Change (1 day)
-47.88%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -NZ$36.91 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are NZ$8.71 Million. In 2023 the company made an earning of -NZ$43.85 Million a decrease over its 2022 earnings that were of -NZ$39.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$36.91 Million-15.84%
2023 -NZ$43.85 Million9.83%
2022 -NZ$39.93 Million-54.24%
2021 -NZ$87.25 Million86.07%
2020 -NZ$46.89 Million-31.97%
2019 -NZ$68.92 Million-5.42%
2018 -NZ$72.87 Million1.1%
2017 -NZ$72.08 Million-31.06%
2016 -NZ$0.11 Billion-10.38%
2015 -NZ$0.12 Billion29.69%
2014 -NZ$89.96 Million31.68%
2013 -NZ$68.32 Million
2011 -NZ$33.16 Million89.78%
2010 -NZ$17.47 Million206.06%
2009 -NZ$5.71 Million-0.58%
2008 -NZ$5.75 Million164.89%
2007 -NZ$2.17 Million-30.22%
2006 -NZ$3.11 Million
2002 -NZ$3.61 Million-41.04%
2001 -NZ$6.12 Million-32.04%
2000 -NZ$9.01 Million-11.85%
1999 -NZ$10.22 Million
1997 -NZ$6.56 Million12.12%
1996 -NZ$5.86 Million106.25%
1995 -NZ$2.84 Million-11.11%
1994 -NZ$3.2 Million50%
1993 -NZ$2.13 Million20%
1992 -NZ$1.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.24 Billion 492.84%๐Ÿ‡บ๐Ÿ‡ธ USA